SCHEMBL10148422

SCHEMBL10148422

C[C@@H](Oc1ccc(C(=O)OCc2ccccc2)cc1)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.59
SLC6A2 P23975 1/20 0.59
SLC6A3 Q01959 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
LMNA P02545 3/20 0.59
FFAR1 O14842 1/20 0.57
MAPT P10636 3/20 0.56
ALDH1A1 P00352 2/20 0.56
HPGD P15428 1/20 0.56
LTB4R Q15722 7/20 0.53
LTB4R2 Q9NPC1 7/20 0.53
RAB9A P51151 2/20 0.51
GAA P10253 1/20 0.51
S1PR5 Q9H228 2/20 0.49
S1PR1 P21453 1/20 0.49
NPC1 O15118 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.48
ALOX5 P09917 1/20 0.48
MEN1 O00255 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10148420 1.00 KMT2A (0.59) KMT2ASLC6A2SLC6A3TDP1LMNA
SCHEMBL7401587 0.87 KMT2A (0.65) KMT2ASLC6A2SLC6A3TDP1LMNA
SCHEMBL6286653 0.86 KMT2A (0.63) KMT2ASLC6A2SLC6A3TDP1LMNA
Benzyl Benzoate SCHEMBL3824242 0.83 KMT2A (0.68) KMT2ASLC6A2SLC6A3TDP1LMNA
SCHEMBL10186403 0.82 LMNA (0.56) TDP1LMNAFFAR1HPGDLTB4R
SCHEMBL10186125 0.82 LMNA (0.56) TDP1LMNAFFAR1HPGDLTB4R
SCHEMBL28881004 0.82 KMT2A (0.76) KMT2ASLC6A2SLC6A3TDP1LMNA
SCHEMBL12391751 0.81 LMNA (0.74) KMT2ASLC6A2SLC6A3TDP1LMNA
SCHEMBL13845264 0.81 KMT2A (0.56) KMT2ASLC6A2SLC6A3TDP1LMNA
SCHEMBL15614364 0.81 KMT2A (0.69) KMT2ASLC6A2SLC6A3TDP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046292-A1 DIACYLETHYLENEDIAMINE COMPOUND ASTELLAS PHARMA INC. (JP) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046292-A1 DIACYLETHYLENEDIAMINE COMPOUND DGAT1, DGAT2, DIMT1 KMT2A 441/4885SLC6A2 428/4885SLC6A3 296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.